RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative

Recruiting N/A Interventional Study
Cannabis Use Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
46 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in otherwise healthy adults seeking to reduce cannabis use in the context of cannabis use disorder (CUD).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Aged 22-65 years (inclusive) 2. Currently meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for CUD, as determined by DSM-V criteria (M.I.N.I) 3. Positive for cannabis on the 11-COOH-THC single panel urine test 4. Seeking treatment to reduce or …
Contacts

Shayna Pehel

929-455-5104

Shayna.Pehel@nyulangone.org

CONTACT

Giuseppina Pilloni

929-455-5317

Giuseppina.Pilloni@nyulangone.org

CONTACT